Moat Ross sold KNSA
April 7, 2026 · Form 4 insider transaction
Moat Ross sold 774 shares of Kiniksa Pharmaceuticals International, plc at $48.94 per share, a transaction worth $37.9K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
774
Price
$48.94
Total value
$37.9K
InsiderMoat Ross
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeF: Shares withheld for taxes
Transaction dateApril 7, 2026
Filing dateApril 8, 2026
Shares owned after13,732
OwnershipDirect
10b5-1 planNo
AmendedNo